MDM2 and B-cell chronic lymphocytic leukemia: This contention is intriguing particularly in light of data reported by Saddler et al. showing that treatment with nutlin-3a, a drug that disrupts the interaction between Mdm2 and p53, efficiently induces apoptosis of B-CLL cells in vitro [25].